homevideos Newsmarket Newsstocks NewsRaw material prices softening; aim to double EBITDA in next 2 3 years: Rossari Biotech
Raw material prices softening; aim to double EBITDA in next 2-3 years: Rossari Biotech
Rossari Biotech has corrected 30 percent in last 3 months. Sunil Chari, Co-founder & MD of Rossari Biotech in an interview to CNBC-TV18 said, margins are likely to increase from Q2FY23 as prices for main raw materials have started declining.
Rossari Biotech has corrected 30 percent in last 3 months.
Sunil Chari, Co-founder & MD of Rossari Biotech in an interview to CNBC-TV18 said, margins are likely to increase from Q2FY23 as prices for main raw materials have started declining.
He said the company expects to do Rs 1,600 crore of revenue in FY22 and double the EBITDA in next 2-3 years.
Watch video for more.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
BJP is planning to ban RSS, says Shiv Sena (UBT) chief Uddhav Thackeray
May 18, 2024 8:01 PM
Punjab Lok Sabha elections: Complete list of Congress candidates
May 18, 2024 4:08 PM
Punjab Lok Sabha elections: Check full list of AAP candidates and constituencies
May 18, 2024 12:59 PM
PM Modi, Rahul Gandhi election rallies in Delhi today: Here are the routes to avoid
May 18, 2024 11:28 AM